Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-23

Clinical Trial Update: Impact of Colchicine in Hospitalized Colombian Patients With COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial investigating colchicine in hospitalized COVID-19 patients in Colombia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Fundación Universitaria de Ciencias de la Salud | Conditions: Corona Virus Infection | Phase 3 | Status: TERMINATED